Csontveló-transzplantációs program Magyarországon: beszámoló az 1990-1995 közötti idószakról.

G. Petrányi, T. Masszi, L. Tímár, G. Kriván, K. Pálóczi, K. Nagy, S. Fekete, P. Reményi, E. Torbágyi, R. Dénes, E. Kelemen

Research output: Article

1 Citation (Scopus)

Abstract

The article summarises the statistical data of bone marrow transplantation (BMT) carried out in Hungary between 1990-1995 in yearly distribution. Since the first BMT up to the end of 1995, 168 BMT were performed. The number of transplantations since 1990 to our days was gradually increasing. As a result of this activity in the three transplantation centers (National Institute of Haematology and Immunology, St. László Hospital and County Hospital in Miskolc) 36 allogeneic and 12 autologous BMT were performed in 1995. Out of the allogeneic BMT cases, 14% of them were completed with unrelated, donors in the last three years. The most frequent indications for allogenic BMT are: chronic myeloid leukaemia (CML), acute lymphoid leukaemia (ALL), acute myeloid leukaemia (AML), myelodysplasia, severe aplastic anaemia. Child allogenic BMTs are carried out on pediatric patients in St. László Hospital in leukaemia, severe aplastic anaemia cases and children born with immunodeficiency. Autologous BMTs started in an organised way in 1995 for adult patients in cases of non-Hodgkin lymphoma, Hodgkin lymphoma and for children with solid tumour indication in the Miskolc Centre. BMT activity in Hungary compared with international data, especially within Europe, shows a significant drop behind. To calculate for ten million inhabitants, the optimal BMT activity should be between 100-200 transplantations (allogeneic and autologous BMT together) in 1994. Among the Central European countries Hungary and Poland fall most behind. Autologous BMTs in most countries of Europe are above of allogeneic BMTs in numbers as indication in cases of lymphoma and solid tumours (first of all mamma carcinoma) comes into focus. This summary emphasises the most important difficulties in connection with the development of the National BMT program.

Original languageHungarian
Pages (from-to)2203-2208
Number of pages6
JournalOrvosi Hetilap
Volume137
Issue number40
Publication statusPublished - okt. 6 1996

Fingerprint

Hungary
Bone Marrow Transplantation
Homologous Transplantation
Aplastic Anemia
Autologous Transplantation
Transplantation
County Hospitals
Unrelated Donors
Animal Mammary Glands
Hematology
Poland
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Allergy and Immunology
Hodgkin Disease
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Non-Hodgkin's Lymphoma
Lymphoma
Neoplasms
Leukemia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Csontveló-transzplantációs program Magyarországon : beszámoló az 1990-1995 közötti idószakról. / Petrányi, G.; Masszi, T.; Tímár, L.; Kriván, G.; Pálóczi, K.; Nagy, K.; Fekete, S.; Reményi, P.; Torbágyi, E.; Dénes, R.; Kelemen, E.

In: Orvosi Hetilap, Vol. 137, No. 40, 06.10.1996, p. 2203-2208.

Research output: Article

Petrányi, G, Masszi, T, Tímár, L, Kriván, G, Pálóczi, K, Nagy, K, Fekete, S, Reményi, P, Torbágyi, E, Dénes, R & Kelemen, E 1996, 'Csontveló-transzplantációs program Magyarországon: beszámoló az 1990-1995 közötti idószakról.', Orvosi Hetilap, vol. 137, no. 40, pp. 2203-2208.
Petrányi, G. ; Masszi, T. ; Tímár, L. ; Kriván, G. ; Pálóczi, K. ; Nagy, K. ; Fekete, S. ; Reményi, P. ; Torbágyi, E. ; Dénes, R. ; Kelemen, E. / Csontveló-transzplantációs program Magyarországon : beszámoló az 1990-1995 közötti idószakról. In: Orvosi Hetilap. 1996 ; Vol. 137, No. 40. pp. 2203-2208.
@article{03b98ebc3de1418f82bd2061b7d5c182,
title = "Csontvel{\'o}-transzplant{\'a}ci{\'o}s program Magyarorsz{\'a}gon: besz{\'a}mol{\'o} az 1990-1995 k{\"o}z{\"o}tti id{\'o}szakr{\'o}l.",
abstract = "The article summarises the statistical data of bone marrow transplantation (BMT) carried out in Hungary between 1990-1995 in yearly distribution. Since the first BMT up to the end of 1995, 168 BMT were performed. The number of transplantations since 1990 to our days was gradually increasing. As a result of this activity in the three transplantation centers (National Institute of Haematology and Immunology, St. L{\'a}szl{\'o} Hospital and County Hospital in Miskolc) 36 allogeneic and 12 autologous BMT were performed in 1995. Out of the allogeneic BMT cases, 14{\%} of them were completed with unrelated, donors in the last three years. The most frequent indications for allogenic BMT are: chronic myeloid leukaemia (CML), acute lymphoid leukaemia (ALL), acute myeloid leukaemia (AML), myelodysplasia, severe aplastic anaemia. Child allogenic BMTs are carried out on pediatric patients in St. L{\'a}szl{\'o} Hospital in leukaemia, severe aplastic anaemia cases and children born with immunodeficiency. Autologous BMTs started in an organised way in 1995 for adult patients in cases of non-Hodgkin lymphoma, Hodgkin lymphoma and for children with solid tumour indication in the Miskolc Centre. BMT activity in Hungary compared with international data, especially within Europe, shows a significant drop behind. To calculate for ten million inhabitants, the optimal BMT activity should be between 100-200 transplantations (allogeneic and autologous BMT together) in 1994. Among the Central European countries Hungary and Poland fall most behind. Autologous BMTs in most countries of Europe are above of allogeneic BMTs in numbers as indication in cases of lymphoma and solid tumours (first of all mamma carcinoma) comes into focus. This summary emphasises the most important difficulties in connection with the development of the National BMT program.",
author = "G. Petr{\'a}nyi and T. Masszi and L. T{\'i}m{\'a}r and G. Kriv{\'a}n and K. P{\'a}l{\'o}czi and K. Nagy and S. Fekete and P. Rem{\'e}nyi and E. Torb{\'a}gyi and R. D{\'e}nes and E. Kelemen",
year = "1996",
month = "10",
day = "6",
language = "Hungarian",
volume = "137",
pages = "2203--2208",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "40",

}

TY - JOUR

T1 - Csontveló-transzplantációs program Magyarországon

T2 - beszámoló az 1990-1995 közötti idószakról.

AU - Petrányi, G.

AU - Masszi, T.

AU - Tímár, L.

AU - Kriván, G.

AU - Pálóczi, K.

AU - Nagy, K.

AU - Fekete, S.

AU - Reményi, P.

AU - Torbágyi, E.

AU - Dénes, R.

AU - Kelemen, E.

PY - 1996/10/6

Y1 - 1996/10/6

N2 - The article summarises the statistical data of bone marrow transplantation (BMT) carried out in Hungary between 1990-1995 in yearly distribution. Since the first BMT up to the end of 1995, 168 BMT were performed. The number of transplantations since 1990 to our days was gradually increasing. As a result of this activity in the three transplantation centers (National Institute of Haematology and Immunology, St. László Hospital and County Hospital in Miskolc) 36 allogeneic and 12 autologous BMT were performed in 1995. Out of the allogeneic BMT cases, 14% of them were completed with unrelated, donors in the last three years. The most frequent indications for allogenic BMT are: chronic myeloid leukaemia (CML), acute lymphoid leukaemia (ALL), acute myeloid leukaemia (AML), myelodysplasia, severe aplastic anaemia. Child allogenic BMTs are carried out on pediatric patients in St. László Hospital in leukaemia, severe aplastic anaemia cases and children born with immunodeficiency. Autologous BMTs started in an organised way in 1995 for adult patients in cases of non-Hodgkin lymphoma, Hodgkin lymphoma and for children with solid tumour indication in the Miskolc Centre. BMT activity in Hungary compared with international data, especially within Europe, shows a significant drop behind. To calculate for ten million inhabitants, the optimal BMT activity should be between 100-200 transplantations (allogeneic and autologous BMT together) in 1994. Among the Central European countries Hungary and Poland fall most behind. Autologous BMTs in most countries of Europe are above of allogeneic BMTs in numbers as indication in cases of lymphoma and solid tumours (first of all mamma carcinoma) comes into focus. This summary emphasises the most important difficulties in connection with the development of the National BMT program.

AB - The article summarises the statistical data of bone marrow transplantation (BMT) carried out in Hungary between 1990-1995 in yearly distribution. Since the first BMT up to the end of 1995, 168 BMT were performed. The number of transplantations since 1990 to our days was gradually increasing. As a result of this activity in the three transplantation centers (National Institute of Haematology and Immunology, St. László Hospital and County Hospital in Miskolc) 36 allogeneic and 12 autologous BMT were performed in 1995. Out of the allogeneic BMT cases, 14% of them were completed with unrelated, donors in the last three years. The most frequent indications for allogenic BMT are: chronic myeloid leukaemia (CML), acute lymphoid leukaemia (ALL), acute myeloid leukaemia (AML), myelodysplasia, severe aplastic anaemia. Child allogenic BMTs are carried out on pediatric patients in St. László Hospital in leukaemia, severe aplastic anaemia cases and children born with immunodeficiency. Autologous BMTs started in an organised way in 1995 for adult patients in cases of non-Hodgkin lymphoma, Hodgkin lymphoma and for children with solid tumour indication in the Miskolc Centre. BMT activity in Hungary compared with international data, especially within Europe, shows a significant drop behind. To calculate for ten million inhabitants, the optimal BMT activity should be between 100-200 transplantations (allogeneic and autologous BMT together) in 1994. Among the Central European countries Hungary and Poland fall most behind. Autologous BMTs in most countries of Europe are above of allogeneic BMTs in numbers as indication in cases of lymphoma and solid tumours (first of all mamma carcinoma) comes into focus. This summary emphasises the most important difficulties in connection with the development of the National BMT program.

UR - http://www.scopus.com/inward/record.url?scp=0030572776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030572776&partnerID=8YFLogxK

M3 - Article

C2 - 8927370

AN - SCOPUS:0030572776

VL - 137

SP - 2203

EP - 2208

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 40

ER -